Skip to main content

Table 2 Systemic foci of TB involvement

From: Efficacy and safety of thrice weekly DOTS in tuberculosis patients with and without HIV co-infection: an observational study

 

HIV + (n = 150)

HIV- (n = 155)

Overall (n = 305)

Pulmonary TB

89 (59.3%)

119 (76.8%)

208 (68.2%)

Pulmonary only

49 (32.7%)

111 (71.6%)

160 (52.5%)

Miliary

2 (1.3%)

2 (1.3%)

4 (1.3%)

Disseminated*

38 (25.3%)

6 (3.9%)

44 (14.4%)

Extrapulmonary TB

61 (40.7%)

36 (23.2%)

97 (31.8%)

Lymph node

35 (23.3%)

23 (14.8%)

58 (19.0%)

Pleural

5 (3.3%)

4 (2.6%)

9 (3.0%)

Intestinal

0

1 (0.6%)

1 (0.3%)

Genitourinary

0

1 (0.6%)

1 (0.3%)

Peritoneal (ascites)

0

1 (0.6%)

1 (0.3%)

Disseminated*

21 (14%)

6 (3.9%)

27 (8.9%)

  1. * Dissemination was defined as involvement of two or more non-contiguous organ sites [27]. Patients were labelled as ‘pulmonary, disseminated’ in case of presence of concomitant pulmonary and distant extrapulmonary disease, or ‘extrapulmonary, disseminated’ if there was evidence of dissemination without any lung parenchymal involvement.
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us